EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?. (2024). Mediterranean Journal of Hematology and Infectious Diseases, 16(1), e2024073. https://doi.org/10.4084/MJHID.2024.073